J Bacteriol, January 1998, p. 190-193, Vol. 180, No. 1
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The leuO Gene Product Has a Latent
Ability To Relieve bgl Silencing in
Escherichia coli
Chiharu
Ueguchi,*
Tomoko
Ohta,
Chiharu
Seto,
Tomomi
Suzuki, and
Takeshi
Mizuno
Laboratory of Molecular Microbiology, School
of Agriculture, Nagoya University, Chikusa-ku, Nagoya 464, Japan
Received 2 July 1997/Accepted 17 October 1997
 |
ABSTRACT |
The Escherichia coli bgl operon is of interest, since
its expression is silent (phenotypically Bgl
), at least
under standard laboratory conditions. Here we attempted to identify a
trans-acting factor(s) that is presumably relevant to the
regulation of bgl by a random insertion mutagenesis with mini-Tn10. These collected mutations, conferring the
phenotype of Bgl+, were localized in three loci on the
genetic map, two of which appeared to be hns and
bglJ, which were previously implicated as the factors
affecting the Bgl phenotype. The other locus at 1 to 2 min on the
genetic map appeared to be a new one. In this case, the insertion
mutation was found to be just in front of the leuO gene
encoding a putative LysR-like DNA-binding protein. Genetic analyses
revealed that overproduction of LeuO in the wild-type cells causes the
phenotype of Bgl+. A leuO deletion mutant was
also characterized in terms of expression of bgl. From
these results, the possible function of LeuO in bgl expression will be discussed from an evolutionary and/or ecological point of view.
 |
TEXT |
The bgl operon, located
at about 84 min on the Escherichia coli K-12 genetic map, is
involved in the utilization of certain
-glucosides, such as salicin
and arbutin (9, 15). This operon is of interest in that,
although it is intact in the genetic sense (bgl+), its expression is normally silent in the
wild-type background (i.e., phenotypically Bgl
) but is
enhanced upon the occurrence of various types of spontaneous mutations,
resulting in a phenotype of Bgl+. Such Bgl+
mutations include insertion of IS1 or IS5
upstream of the bgl promoter, point mutations within a CRP
(cyclic AMP receptor protein) binding site and deletions within a
region upstream of the CRP binding site (10, 11, 13, 14).
Interestingly, mutations outside the bgl operon can also
result in Bgl+. Specifically, certain mutations in the
genes encoding the subunits of DNA gyrase (gyrA and
gyrB) or the H-NS nucleoid protein (hns [formerly called bglY]) can activate the bgl
operon (1, 2). Recently, another trans-acting
gene, named bglJ, was reported to affect bgl
silencing, although its significance is less clear (3). In
this context, the molecular mechanism underlying bgl silencing has previously been characterized to some extent, and a
plausible model of Schnetz (12) postulated that a region of the bgl operon including its promoter is organized into a
nucleoprotein structure, within which the activity of the
bgl promoter is repressed somehow. Nevertheless, no clear
picture with regard to such a "silencing nucleoprotein structure"
has emerged.
Based on a number of current studies, it is believed that H-NS is
directly implicated in the formation of such a presumed silencing
nucleoprotein structure (12, 16). From our recent results,
however, it is also evident that the DNA-binding ability of H-NS is
dispensable for bgl silencing (21). That is, a
carboxyl-terminally truncated form of H-NS, lacking the entire
DNA-binding domain, is still able to fully repress bgl
expression. This fact may suggest that other trans-acting
DNA-binding protein(s) must also be involved in bgl
silencing. In this study, we thus attempted to search for such a new
trans-acting factor(s) that may be relevant to the underlying mechanism of bgl silencing.
Isolation of Bgl+ mutants.
A method of transposon
mutagenesis with mini-Tn10cam (cam gene confers
chloramphenicol resistance [Cmr]) (7) was
adopted by employing a specialized E. coli strain (BGL1),
which was designed to carry not only the intact bgl operon on the chromosome but also a bgl-lacZ fusion gene at the
att site (21). Note that this particular
strain is phenotypically Bgl
and LacZ
due
to bgl silencing. Cells of CSH26 [
(pro-lac)
ara thi], which is the parental strain of BGL1, were
extensively mutagenized with mini-Tn10cam. Then, P1 phage
lysates from the mutagenized cells were used for P1 transduction into
strain BGL1, yielding 3.6 × 104 Cmr
cells. Among these cells, we searched for trans-acting
mutants, which should exhibit simultaneously the phenotypes of
Bgl+ and LacZ+. The former was screened on agar
plates containing salicin and bromothymol blue, and the latter was
screened on MacConkey-lactose plates containing salicin. After such an
extensive double screening, we isolated 29 mutants that exhibited the
desirable phenotypes of Cmr, Bgl+, and
LacZ+. They were assumed to carry a Tn10
insertion mutation in a certain trans-acting gene, thereby
resulting in a relief of bgl silencing. The positions of
these 29 mutations on the E. coli chromosome were roughly
mapped by P1 transduction with the help of a large set of
Tn10 insertions in the entire E. coli chromosome,
which were previously constructed by Singer et al. (zxx
series::Tn10) (20). This whole set of
Tn10 insertions provided us with appropriate markers
(Tetr [tetracycline resistant]), whose positions are
known and located evenly on the entire E. coli chromosome.
The results of such analyses showed that 12 mutations (class A) were
linked to zab-3051::Tn10 (1 to 2 min on
the chromosome) (99% linkage), 11 mutations (class B) were linked to
zci-506 (27 to 28 min) (80% linkage), and the remainder
(class C) were linked to zji-202::Tn10
(98 to 99 min) (80% linkage). Together with the previous notions with
regard to the trans-acting mutations affecting
bgl silencing (see the introduction), we assumed that class
A mutations most likely represent a novel mutation, while the other
classes, B and C, correspond to each known gene, hns and
bglJ, respectively. From these 29 mutants, we thus selected
representative strains for each class (namely, CU305 for class A, CU306
for class B, and CU307 for class C).
With these representatives, we first demonstrated that each mutant does
indeed exhibit the expected phenotype, Bgl+, by monitoring
expression of the bgl-lacZ fusion in these mutants (Fig.
1A). The levels of
-galactosidase
activities, expressed in these mutants, increased in an inducer
(
-methyl-D-glucoside)-dependent manner, as remarkably as
in the case of the known hns deletion mutant. Thus, we
succeeded in isolating at least one new class of Bgl+
mutants, in which the mini-Tn10cam insertion results in a
relief of bgl silencing. We then focused our attention on
this particularly new mutant, CU305, while the presumed hns
and bglJ mutants, CU306 and CU307, were discarded.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Expression of the bgl operon in the set
of transposon insertion mutants. Cells of the indicated strains, all
carrying a bgl-lacZ transcriptional fusion on the
chromosome, were grown at 37°C to mid-logarithmic phase in TB medium
(19) in the absence ( ) and presence (+) of 5 mM
-methyl-D-glucoside, an inducer for the bgl
operon. -Galactosidase activities expressed by these cells were
measured by the method of Miller (8). Each value is the
mean ± standard deviation from four independent assays. (B)
Expression of the bgl operon in the cells in which LeuO is
overproduced. Transformants of BGL1 with pTO3 (see FIG. 2C) or pUSI2 (a
control vector) were grown, and then -galactosidase activities
expressed by these cells were measured, as described above.
|
|
Derepression of bgl expression in CU305 is due to
overproduction of LeuO.
By employing standard techniques of
recombinant DNA, we clarified the structure of the chromosomal region
of CU305 where mini-Tn10cam had been inserted (Fig.
2A). The inserted element was found to be
19 bp upstream of the known open reading frame (ORF), named leuO, which is located at 1.8 min on the E. coli
genetic map, and between the leuABCD and ilvIH
operons. The leuO gene specifies a putative DNA-binding
protein, which appears to be a member of the LysR family of regulatory
proteins (6). Based on its location on the map (Fig. 2A), it
has previously been speculated that LeuO might be implicated in the
regulation of the leuABCD operon, but no evidence for such a
role has been reported (e.g., in fact, the
leuO strain
constructed in this study is not leucine auxotrophic). In CU305, this
leuO ORF is not interrupted by the mini-Tn10cam insertion. Then, the question of how this particular insertion causes
the Bgl+ phenotype arose. Among several explanations
envisaged, we first tested the idea that overproduction of LeuO, due to
the mini-Tn10cam insertion upstream of the coding sequence,
may result in the Bgl+ phenotype. This was found to be the
case, as demonstrated below. The leuO gene was cloned, and
placed under the isopropyl-
-D-thiogalactopyranoside (IPTG)-inducible tac promoter in a versatile expression
vector (named pUSI2) (18), to yield pTO3 (Fig. 2C). When
this plasmid was introduced into the wild-type background (BGL1), it
was found that expression of bgl-lacZ was greatly enhanced
in a manner dependent on the presence of IPTG (Fig. 1B). The level of
bgl expression was more or less the same as in the case of
CU305. These results collectively supported the view that
overexpression of LeuO somehow results in the phenotype of
Bgl+. In this respect, it may be noted that, although it
was previously reported that overproduction of LeuO negatively affects
cadBA expression (17), the result described here
demonstrated that overproduction of LeuO also has a somewhat positive
effect on expression of this particular operon (bgl).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Schematic representations of leuO mutations
on the chromosome and of the cloned leuO gene on the
plasmid. (A) Structure of the chromosomal region encompassing the
leuO gene is shown schematically, in which the position of
the mini-Tn10cam insertion in CU305 was indicated. Each
polygonal symbol shows the indicated ORFs as well as their relative
directions of transcription (the letter P shows each putative
promoter). (B) Construction of the
leuO::cam deletion mutation used in
this study. The BstXI-ApaI DNA region
encompassing the leuO coding sequence was replaced by the
DNA fragment carrying the cam (Cmr) gene on the
chromosome of TO2. (C) Construction of the plasmid pTO3 that can
overproduce LeuO. The EcoT22I-VspI fragment
encompassing the entire region of the leuO gene was cloned
under the tac promoter on pUSI2 (17), to yield
pTO3.
|
|
Overproduction of LeuO affects bgl expression in
H-NS-independent manner.
We then asked the question of what might
be the possible mechanism underlying bgl derepression caused
by LeuO overproduction. We focused our attention particularly on a
possible linkage between the functions of H-NS and LeuO, since H-NS is
a major trans-acting factor, so far known to be implicated
in the bgl silencing (1, 16). Based on the fact
that expression of the bgl operon is fully derepressed in a
hns background (Fig. 1A), one can assume that
overproduction of LeuO might cause inactivation of H-NS either directly
or indirectly, which in turn should result in bgl
derepression. However, we found by an immunoblotting analysis with an
anti-H-NS antiserum that the cellular content of H-NS in CU305 is
essentially the same as that in its parental cells (data not shown). We
also confirmed that H-NS in strain CU305 is fully functional, because the expression of the proVWX operon is not derepressed by
the LeuO overproduction (data not shown). Note that whether H-NS is functional can be monitored sensitively by examining whether the proVWX operon is depressed, as demonstrated previously
(21). Thus, the above assumption was dismissed.
The further question was what would happen if the leuO gene
on the wild-type chromosome were knocked out. To see this consequence with special reference to bgl silencing, a region on the
BGL1 chromosome was replaced by a chloramphenicol-resistant cassette, so as to yield a
leuO::cam mutant
(Fig. 1B). The resultant strain, named TO2, was examined for
bgl silencing by monitoring bgl-lacZ expression,
showing that no effect was seen (Fig. 3).
This result suggested that LeuO is not essential to keep the
bgl operon to be silent. We then needed to see the phenotype
of the leuO deletion mutation in appropriate genetic
backgrounds, under which bgl silencing had been relieved. To
do so, the
hns mutation was again concerned, since
expression of the bgl operon is fully derepressed in this background (21). A strain with both the
hns
and
leuO mutations was constructed and examined for
bgl expression. Again, no effect was seen (Fig. 3),
suggesting that LeuO is not essential for bgl transcription
at least under certain conditions.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of the bgl operon in the
leuO deletion mutant. A set of strains including BGL1 (wild
type), TO2 ( leuO), BGL1
hns::neo (an
hns::neo derivative of BGL1), and TO3
(an hns::neo derivative of TO2) were
assayed for their expression of bgl-lacZ. The cells were
grown at 37°C to the mid-logarithmic phase in TB medium
(19) in the absence ( ) and presence (+) of 5 mM
-methyl-D-glucoside, and then -galactosidase
activities expressed were measured by the method of Miller
(8). Each value is the mean ± standard deviation from
four independent assays.
|
|
LeuO is a LysR-like protein, and thus, it is most likely a DNA-binding
protein. In this study, we found that LeuO is able to lead the
bgl operon to its derepressed state (i.e.,
Bgl+), even in the presence of H-NS, provided that LeuO was
overexpressed under certain conditions. It is not known at present how
LeuO can do this task. However, we demonstrated that LeuO appears not to exert its function through H-NS, which is a major contributor for
bgl silencing. It was also found that LeuO is not required for bgl activation caused by the
hns mutation.
These results suggest that LeuO exhibits its effect on the
bgl operon in an H-NS-independent manner, that is, LeuO can
fully antagonize the negative effect of H-NS on the bgl
operon. Thus, LeuO may function as an activator for the bgl
operon through its direct binding to this target. Alternatively, LeuO
may have the ability to disrupt the presumed silencing nucleoprotein
structure on the bgl promoter. Of course, more complex
explanations cannot be excluded at present. In any case, it will be of
interest to see whether LeuO can bind directly to a region of the
bgl operon.
Implications.
It is not clear at present whether the
single-copy leuO gene is relevant to the regulation of the
bgl operon, because we have not so far succeeded in finding
a phenotype for the leuO deletion mutant. However, it can be
assumed that there may be certain natural conditions under which the
expression of LeuO is enhanced. Under such a presumed circumstance, the
bgl operon would be inducibly activated. In this context, it
is also worth mentioning that these features of LeuO, described here,
are very similar to those of BglJ (3). Overproduction of
BglJ, caused by an IS insertion, was also reported to result in the
phenotype of Bgl+. This protein belongs to yet another type
of DNA-binding protein, a NarL/RcsB-like protein with a potential
helix-turn-helix motif. These facts suggest that E. coli has
at least two potential activators, which can relieve the tight
bgl silencing. If they can exert a redundant effect on the
bgl operon, then the leuO deletion mutation alone
would not show any noticeable phenotype with regard to the bgl operon. It will be thus of interest to construct a
leuO
bglJ double mutant in order to see the
Bgl phenotype.
In connection with a physiological significance of our finding, the
issue should finally be addressed of why E. coli must keep
the bgl operon, which can be activated (or used) only upon fortuitous mutations, and is otherwise useless. Why should E. coli have such proteins, like LeuO, which possesses a powerful but
latent ability to activate the bgl operon? As pointed out by
Giel et al. (3), one might expect that the bgl
operon in E. coli would be lost eventually. Instead, the
silent bgl operon is present in a variety of E. coli strains isolated from different geographical locations
(4). Hall et al. (5) have proposed that the
presence of the bgl operon, which can be activated solely by
mutation, may confer a selective advantage to those organisms that have
maintained this cryptic system (i.e., the bgl-leuO system). If so, with the onset of an urgent situation in nature, potential trans-acting genes for the bgl operon, like
leuO and bglJ, may serve as a secret weapon,
which can be triggered by naturally occurring IS insertions. From an
evolutionary and/or ecological point of view, this may be one of the
positive physiological functions of leuO.
 |
ACKNOWLEDGMENTS |
We thank Y. Nakamura (Institute for Medical Science, University of
Tokyo) and K. Ito (Institute for Virus Research, Kyoto University) for
their kind gifts of a system for mini-Tn10cam transposition
and a set of Tn10 insertions (zxx
series::Tn10), respectively.
This work was supported by grants from the Ministry of Education,
Science and Culture of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Molecular Microbiology, School of Agriculture, Nagoya University,
Chikusa-ku, Nagoya 464, Japan. Phone: (81)-52-789-4089. Fax:
(81)-52-789-4091. E-mail:
cueguchi{at}nuagr1.agr.nagoya-u.ac.jp.
 |
REFERENCES |
| 1.
|
Defez, R., and M. De Felice.
1981.
Cryptic operon for -glucoside metabolism in Escherichia coli K12: genetic evidence for a regulatory protein.
Genetics
97:11-25[Abstract/Free Full Text].
|
| 2.
|
DiNardo, S.,
K. A. Voelkel,
R. Sternglanz,
A. E. Reynolds, and A. Wright.
1982.
Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes.
Cell
31:43-51[Medline].
|
| 3.
|
Giel, M.,
M. Desnoyer, and J. Lopilato.
1996.
A mutation in a new gene, bglJ, activates the bgl operon in Escherichia coli K12.
Genetics
143:627-635[Abstract].
|
| 4.
|
Hall, B. G.
1988.
Widespread distribution of deletions of the bgl operon in natural isolates of Escherichia coli.
Mol. Biol. Evol.
5:456-467[Abstract].
|
| 5.
|
Hall, B. G.,
S. Yokoyama, and D. H. Calhoun.
1983.
Role of cryptic genes in microbial evolution.
Mol. Biol. Evol.
1:109-124[Abstract].
|
| 6.
|
Henikoff, S.,
G. W. Haughn,
J. M. Calvo, and J. C. Wallace.
1988.
A large family of bacterial activator proteins.
Proc. Natl. Acad. Sci. USA
85:6602-6606[Abstract/Free Full Text].
|
| 7.
|
Kleckner, N.,
J. Bender, and S. Gottesman.
1991.
Uses of transposons with emphasis on Tn10.
Methods Enzymol.
204:139-180[Medline].
|
| 8.
|
Miller, J. H.
1972.
.
Experiments in molecular genetics.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 9.
|
Prasad, I., and S. Schaefler.
1974.
Regulation of the -glucoside system in Escherichia coli K-12.
J. Bacteriol.
120:638-650[Abstract/Free Full Text].
|
| 10.
|
Reynolds, A. E.,
J. Felton, and A. Wright.
1981.
Insertion of DNA activates the cryptic bgl operon in E. coli.
Nature (London)
293:625-629[Medline].
|
| 11.
|
Reynolds, A. E.,
M. Subramony,
S. F. G. LeGrice, and A. Wright.
1984.
Enhancement of bacterial gene expression by insertion elements or by mutation in a CAP-cAMP binding site.
J. Mol. Biol.
191:85-95.
|
| 12.
|
Schnetz, K.
1995.
Silencing of Escherichia coli bgl promoter by flanking sequence elements.
EMBO J.
14:2545-2550[Medline].
|
| 13.
|
Schnetz, K., and B. Rak.
1988.
Regulation of the bgl operon of Escherichia coli by transcriptional antitermination.
EMBO J.
7:3271-3277[Medline].
|
| 14.
|
Schnetz, K., and B. Rak.
1992.
IS5: a mobile enhancer of transcription in Escherichia coli.
Proc. Natl. Acad. Sci. USA
89:1244-1248[Abstract/Free Full Text].
|
| 15.
|
Schnetz, K.,
C. Toloczyki, and B. Rak.
1987.
-Glucoside (bgl) operon of Escherichia coli K-12: nucleotide sequence, genetic organization, and possible evolutionary relationship to regulatory components of two Bacillus subtilis genes.
J. Bacteriol.
169:2579-2590[Abstract/Free Full Text].
|
| 16.
|
Schnetz, K., and J. C. Wang.
1996.
Silencing of the Escherichia coli bgl promoter: effects of template supercoiling and cell extracts on promoter activity in vitro.
Nucleic Acids Res.
24:2422-2428[Abstract/Free Full Text].
|
| 17.
|
Shi, X., and G. N. Bennett.
1995.
Effects of multicopy LeuO on the expression of the acid-inducible lysine decarboxylase gene in Escherichia coli.
J. Bacteriol.
177:810-814[Abstract/Free Full Text].
|
| 18.
|
Shibui, T.,
M. Uchida, and Y. Teranishi.
1988.
A new hybrid promoter and its expression vector in Escherichia coli.
Agric. Biol. Chem.
52:983-988.
|
| 19.
|
Silhavy, T. J.,
M. L. Berman, and L. W. Enquist.
1984.
.
Experiments with gene fusions.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 20.
|
Singer, M.,
T. A. Baker,
G. Schnitzler,
S. M. Deischel,
M. Goel,
W. Dove,
K. J. Jaacks,
A. D. Grossman,
J. W. Erickson, and C. A. Gross.
1989.
A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli.
Microbiol. Rev.
53:1-24[Abstract/Free Full Text].
|
| 21.
|
Ueguchi, C.,
T. Suzuki,
T. Yoshida,
K. Tanaka, and T. Mizuno.
1996.
Systematic mutational analysis revealing the functional domain organization of Escherichia coli nucleoid protein H-NS.
J. Mol. Biol.
263:149-162[Medline].
|
J Bacteriol, January 1998, p. 190-193, Vol. 180, No. 1
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.